Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Web – sheet or filament bases; compositions of bandages; or...
Patent
1996-12-02
1998-05-26
Azpuru, Carlos A.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Web, sheet or filament bases; compositions of bandages; or...
424 7802, 424 7807, 424405, 514262, 514265, 514266, 514357, 514931, 514934, 514969, 546331, A61K 970, A61K 3174, A61K 3152, A01N 4390
Patent
active
057561168
ABSTRACT:
Compositions for topical use in herpes virus infections comprising anti-herpes nucleoside analogue phosphate esters, such as acyclovir monophosphate and acyclovir diphosphate, which show increased activity against native strains of herpes virus as well as against resistant strains, particularly thymidine kinase negative strains of virus. Also disclosed are methods for using the topical compositions in treatment of herpes disease.
REFERENCES:
patent: 4146715 (1979-03-01), Schaeffer
patent: 4199574 (1980-04-01), Schaeffer
patent: 4294831 (1981-10-01), Schaeffer
patent: 4323573 (1982-04-01), Schaeffer
patent: 4360522 (1982-11-01), Schaeffer
patent: 4634719 (1987-01-01), Takaishi et al.
patent: 4758572 (1988-07-01), Spector et al.
patent: 4897394 (1990-01-01), Zimmerman et al.
patent: 5021437 (1991-06-01), Blumenkopf
patent: 5223263 (1993-06-01), Hostetler et al.
patent: 5274162 (1993-12-01), Glazier
Agranoff, B. et al. (1963) Cytidine Diphosphatase--dl--Dipalmitin. Biochem. Prep. 10:47-51.
Ellis, M. et al. (1989) Orofacial infection of athymic mice with defined mixtures of acyclovir-susceptible and acyclovir-resistant herpes simplex virus type 1. Antimicrobial Agents and Chemotherapy 33(3):304-310.
Furman, P. et al., (1979) Inhibition of herpes simplex virus-induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxyethoxymethyl)guanine and its triphosphate. J. Virol. 32:72-77.
Fyfe, J. et al. (1978) Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl)guanine. J. Biol. Chem. 253:8721-8727.
Gomex-almaguer, D. et al. (1988) Acyclovir in the treatment of aplastic anemia. Amer. J. of Hematology 29:172-173.
King (1988) History, pharmacokinetics, and pharmacology of acyclover. J. Am. Acad. Dermatol. 18:176-179 (Abstract only).
Krenitsky, T. et al. (1990) Nucleotide analogue inhibitors of purine nucleoside phosphorylase. The Journal of Biological Chemistry 265(6):3066-3069.
Lobe, D. et al. (1991) Synergistic topical therapy by acyclovir and A11OU for herpes simplex virus induced zosteriform rash in mice. Antiviral Research 15:87-100.
Masch et al. (1965) Nivea, the Prototype of Lanolin Absorption Creams. A history of Nivea Cream. American Perfumer and Cosmetics 80:35-38.
Merta et al. (1990) Inhibition of herpes simplex virus DNA polymerase by diphosphates of acyclic phosphonylmethoxyalkyl nucleotide analogues. Antiviral Research 13:209-218.
O'Brien, W. et al. (1990) Nucleoside metabolism in herpes simplex virus-infected cells following treatment with interferon and acyclovir, a possible mechanism of synergistic antiviral activity. Antimicrob. Agents and Chemother. 34(6):1178-1182.
Ott, D.G. et al. (1967) Chemical synthesis of nucleoside triphosphates. Anal. Biochem. 21:469-472.
Remington's Pharmaceutical Sciences, 15th Edition., 175. Mack Publishing Company., Easton, Pennsylvania 18042. (Chapter 87: Blaug, Seymour).
Rune, S.J. et al. (1990) Acyclovir in the prevention of duodenal ulcer recurrence. Gut 31:151-152.
Spruance, S. et al. (1982) Treatment of herpes simplex labialis with topical acyclovir in polyethylene glycol. J. Infect. Dis. 146:85-90.
Spruance, S. et al. (1984) Early patient-initiated treatment of herpes labialis with topical 10% acyclovir. Antimicrob. Agents Chemother. 25:553-555.
Straus, S. (1989) Effect of oral acyclovir treatment on symptomatic and asymptomatic virus shedding in recurrent genital herpes. Sexually Transmitted Diseases 16(2):107-113.
Toorchen, D. et al. (1983) Mechanisms of chemical mutagenesis and carcinogenesis: effects on DNA replication of methylation at the 06-guanine position of dGTP. Carcinogenesis 4:1591-1597.
Welch, C.J. et al. (1985) The chemical synthesis and antiviral properties of an acyclovir-phospholipid conjugate. Acta Chemica Scandinavica B39:47-54.
Whitley, R. et al. (1990) Immunobiology and Prophylaxis of Human Herpesvirus Infections, C. Lopex (ed), Plenum Press, New York pp. 243-253.
Yoshikawa, M. et al. (1969) Phosphorylation. III. Selective phosphorylation of unprotected nucleosides. Bull. Chem. Soc. Japan 42:3505-3508.
Yoshikawa, et al. (1967) A novel method for phosphorylation of nucleosides to 5'-nucleotides. Tetrahedron Lett., 50:5065-5068.
Leibman, K., et al. (1955) The metabolism of P.sup.32 -labeled ribonucleotides in tissue slices and cell suspensions. J. Bio. Chem. 216:823-830.
Glazier, A., et al. The metabolism and antiviral activity of a novel group of anti-herpes prodrugs. Paper No. 90, presented at The Ninth International Conference on Antiviral Research. Uribandai, Fukushima, Japan, May 23, 1996.
LandOfFree
Nucleoside phosphate therapy for viral infection does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleoside phosphate therapy for viral infection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleoside phosphate therapy for viral infection will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1957427